TipRanks
Go Ultimate55% OFF

Rayonier Advanced Materials (RYQ) AI Stock Analysis

DE:RYQ

Rayonier Advanced Materials

(Frankfurt:RYQ)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Cellulose Specialties momentumStrong pricing and volume gains in Cellulose Specialties indicate improving demand and commercial execution in the company’s higher-value segment. If sustained, this mix improvement can support better utilization, stronger contribution margins, and a more durable earnings recovery over the next several quarters.
Negative Factors
Persistent unprofitabilityThe company remains loss-making despite recent operational improvement, while its very thin gross margin leaves limited protection against weaker pricing or higher costs. Persistent negative returns reduce retained capital, constrain investment capacity, and make the recovery dependent on sustained execution.

Rayonier Advanced Materials (RYQ) vs. iShares MSCI Germany ETF (EWG)

-20%0%20%40%60%80%100%DE:RYQ+4.59%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 447.13M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-3.2
Beta (1Y)
0.46
Revenue Growth
-10.19%
EPS Growth
69.71%
Country
Germany
Employees
2,325
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Rayonier Advanced Materials Business Overview & Revenue Model

Company Description

Rayonier Advanced Materials Inc. operates as a global supplier of specialty cellulose products, reaching markets across the United States, China, Canada, Japan, Europe, Latin America, and other Asian and international regions. Its operations are stru...

Rayonier Advanced Materials Earnings Call Summary

Earnings Call Date:Aug 03, 2026(Q2-2026)|% Change Since:-24.00%|Next Earnings Date:Nov 02, 2026
Earnings Call SentimentPositive

The call described clear sequential operational and financial improvement (stronger sales, a meaningful uplift in adjusted EBITDA driven by Cellulose Specialties, improving cash generation and maintained liquidity and covenant compliance). Management emphasized an active, disciplined strategic review, operational improvement initiatives and a path to positive full-year free cash flow. Offsetting these positives are persistent weaknesses in Paperboard & High-Yield Pulp (negative EBITDA), pricing pressure in commodity grades, an impairment charge, elevated leverage and uncertainty from tariffs and trade proceedings. Overall, the tone is constructive and focused on execution with visible momentum, but material risks remain tied to refinancing, tariff outcomes and turnaround of weaker segments.

Positive Updates

Strong Sequential and Year-over-Year Sales Improvement
Net sales of $376 million, up 18% sequentially and 11% year-over-year, driven primarily by the High Purity Cellulose (HPC) segment.

Negative Updates

Continuing Loss from Operations and Impairment
Loss from continuing operations of $33 million (improved from $81 million in Q1) that included a $13 million noncash asset impairment charge related to high-yield pulp.

Company Guidance

Management reiterated that the strategic review remains a top priority and will be concluded with a clear path in Q4, and that the company remains on track to generate positive free cash flow for full‑year 2026 with the full‑year FCF trajectory aligned with prior expectations. They expect second‑half improvement driven by Cellulose Specialties—Q2 CS pricing was +21% year‑over‑year (+8% sequentially) with CS volumes +19% sequentially and management sees another ~10–15% volumes improvement in the back half—while cellulose commodities should see modest improvement and paperboard a firmer pricing outlook. Q2 results underpinning the guidance included net sales $376M (+18% seq, +11% YoY), adjusted EBITDA $40M (Q1 $8M; prior year $28M), HPC adjusted EBITDA $57M (19% margin), paperboard/high‑yield pulp net sales $75M (Adj. EBITDA -$10M), liquidity $145M (cash $57M, ABL $76M, France $12M), adjusted net debt $755M, net secured debt $726M and net secured leverage 4.2x vs a 4.75x covenant; YTD cash from operations $37M and YTD adjusted free cash flow -$8M (improved $57M YoY).

Rayonier Advanced Materials Risk Analysis

Rayonier Advanced Materials disclosed 30 risk factors in its most recent earnings report. Rayonier Advanced Materials reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Rayonier Advanced Materials Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:RYQ against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IOSPIOSP76Outperform$2.46B20.349.15%1.79%2.87%534.76%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
SCLSCL61Neutral$1.58B366.370.36%2.27%10.02%-90.50%
NGVTNGVT58Neutral$2.55B48.2685.17%―-12.42%―
FFFF53Neutral$248.71M-8.10-19.75%2.47%-7.63%-15.10%
MTXMTX46Neutral$1.95B-28.78-4.12%0.77%4.76%-19991.67%

* Basic Materials Sector Average

Performance Comparison

-20%0%20%40%60%DE:RYQFFIOSPMTXSCLNGVTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:RYQ and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:RYQRayonier Advanced Materials5.700.101.79%
FFFuturefuel5.671.9451.89%
IOSPInnospec99.8927.1337.28%
MTXMinerals Technologies62.746.9512.46%
SCLStepan Company69.6128.3568.72%
NGVTIngevity74.3220.4838.04%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.